The Wisconsin Technology Innovation Initiative (Wi2), a non-profit organization formed to support the School of Medicine and Public Health at the University of Wisconsin-Madison, and Orion Corporation, a Finnish pharmaceutical and diagnostics company, have formed a strategic collaboration in pursuit of new medicines for oncological diseases.   Target proteins (modes of action) identified and initially validated at UW-Madison will be provided to Orion as a first step in establishing a research ...